Literature DB >> 28366537

HIF has Biff - Crosstalk between HIF1a and the family of bHLH/PAS proteins.

Emily L Button1, David C Bersten1, Murray L Whitelaw2.   

Abstract

Two decades of research into functions of the ubiquitous transcription factor HIF have revealed pervasive roles in development, oxygen homeostasis, metabolism, cancer and responses to ischemia. Unsurprisingly, HIF activities impinge on many pathologies, for which underlying molecular mechanisms are actively sought. HIF is a member of the heterodimeric bHLH/PAS family of transcription factors, a set of proteins that commonly function in developmental pathways and adaptive responses to environmental or physiological stress. Similarities in the mechanisms that regulate gene targeting by these transcription factors create opportunities for extensive crosstalk between family members. Data supporting pathway interactions between HIF1a and other bHLH/PAS factors, both collaborative and antagonistic, is beginning to surface in the areas of cancer, circadian rhythm, and immune responses. This review summarises the status of HIF1a-bHLH/PAS protein crosstalk and is dedicated to the memory of Lorenz Poellinger, a pioneer investigator into the molecular mechanisms of HIF, AHR, and ARNT bHLH/PAS factors. Crown
Copyright © 2017. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Basic helix loop helix Per Arnt Sim; Hypoxia inducible factor

Mesh:

Substances:

Year:  2017        PMID: 28366537     DOI: 10.1016/j.yexcr.2017.03.055

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  8 in total

Review 1.  Circadian MicroRNAs in Cardioprotection.

Authors:  Yoshimasa Oyama; Colleen Marie Bartman; Jennifer Gile; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 2.  Circadian-Hypoxia Link and its Potential for Treatment of Cardiovascular Disease.

Authors:  Colleen Marie Bartman; Tobias Eckle
Journal:  Curr Pharm Des       Date:  2019       Impact factor: 3.116

Review 3.  Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.

Authors:  Daniel Desaulniers; Paule Vasseur; Abigail Jacobs; M Cecilia Aguila; Norman Ertych; Miriam N Jacobs
Journal:  Int J Mol Sci       Date:  2021-10-11       Impact factor: 5.923

Review 4.  The Role of Aryl Hydrocarbon Receptor (AhR) in Brain Tumors.

Authors:  Maria L Perepechaeva; Alevtina Y Grishanova
Journal:  Int J Mol Sci       Date:  2020-04-20       Impact factor: 5.923

5.  SMAD4 Overexpression in Patients with Sleep Apnoea May Be Associated with Cardiometabolic Comorbidities.

Authors:  Elena Díaz-García; Ana Jaureguizar; Raquel Casitas; Sara García-Tovar; Begoña Sánchez-Sánchez; Ester Zamarrón; Eduardo López-Collazo; Francisco García-Río; Carolina Cubillos-Zapata
Journal:  J Clin Med       Date:  2020-07-25       Impact factor: 4.241

Review 6.  More than Meets the Eye: The Aryl Hydrocarbon Receptor is an Environmental Sensor, Physiological Regulator and a Therapeutic Target in Ocular Disease.

Authors:  Christine L Hammond; Elisa Roztocil; Vardaan Gupta; Steven E Feldon; Collynn F Woeller
Journal:  Front Toxicol       Date:  2022-03-03

7.  Interaction between AhR and HIF-1 signaling pathways mediated by ARNT/HIF-1β.

Authors:  Mengdi Zhang; Yuxia Hu; Fan Yang; Jingwen Zhang; Jianxin Zhang; Wanjia Yu; Minjie Wang; Xiaoli Lv; Jun Li; Tuya Bai; Fuhou Chang
Journal:  BMC Pharmacol Toxicol       Date:  2022-04-26       Impact factor: 2.605

8.  Characterization of functionally deficient SIM2 variants found in patients with neurological phenotypes.

Authors:  Emily L Button; Joseph J Rossi; Daniel P McDougal; John B Bruning; Daniel J Peet; David C Bersten; Jill A Rosenfeld; Murray L Whitelaw
Journal:  Biochem J       Date:  2022-07-15       Impact factor: 3.766

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.